TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
MD Stock 12 Month Forecast
There Are No Analyst Ratings for MD In The Last 3 Months.
Highest Price Target―
Average Price Target―
Lowest Price Target―
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
MD Financial Forecast
MD Earnings Forecast
Next quarter’s earnings estimate for MD is $0.54 with a range of $0.51 to $0.61. The previous quarter’s EPS was $0.67. MD beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.43% of the time in the same period. In the last calendar year MD has Performed in-line its overall industry.
Next quarter’s earnings estimate for MD is $0.54 with a range of $0.51 to $0.61. The previous quarter’s EPS was $0.67. MD beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.43% of the time in the same period. In the last calendar year MD has Performed in-line its overall industry.
MD Sales Forecast
Next quarter’s sales forecast for MD is $486.23M with a range of $465.50M to $521.66M. The previous quarter’s sales results were $492.88M. MD beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.17% of the time in the same period. In the last calendar year MD has Performed in-line its overall industry.
Next quarter’s sales forecast for MD is $486.23M with a range of $465.50M to $521.66M. The previous quarter’s sales results were $492.88M. MD beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.17% of the time in the same period. In the last calendar year MD has Performed in-line its overall industry.
Pediatrix Medical Group (MD) PT Raised to $18 at MizuhoMizuho analyst Ann Hynes raised the price target on Pediatrix Medical Group (NYSE: MD) to $18.00 (from $15.00) while maintaining a Neutral rating.
We commend the strong performance, appreciate the conservative FY25 bar, and would highlight that MD's profile is consistent with a hypothetical PE M&A candidate. Remain bullish & see upside to FY25 despite honoring the guide w/ our new ests. PT to $21, 12.5x FY25 P/E.
Pediatrix Medical Group (MD) PT Raised to $18 at MizuhoMizuho analyst Ann Hynes raised the price target on Pediatrix Medical Group (NYSE: MD) to $18.00 (from $15.00) while maintaining a Neutral rating.
We commend the strong performance, appreciate the conservative FY25 bar, and would highlight that MD's profile is consistent with a hypothetical PE M&A candidate. Remain bullish & see upside to FY25 despite honoring the guide w/ our new ests. PT to $21, 12.5x FY25 P/E.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of +21.40% per trade.
Copying Jack Slevin's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +35.27% per trade.
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +47.00% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
MD Analyst Recommendation Trends
Rating
Sep 25
Oct 25
Nov 25
Jan 26
Feb 26
Strong Buy
0
0
0
0
0
Buy
5
15
27
52
47
Hold
13
11
9
13
11
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
18
26
36
65
58
In the current month, MD has received 47Buy Ratings, 11Hold Ratings, and 0Sell Ratings. MD average Analyst price target in the past 3 months is ―.
Each month's total comprises the sum of three months' worth of ratings.
MD Stock Forecast FAQ
What is MD’s average 12-month price target, according to analysts?
Currently, no data Available
What is MD’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for MD, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is MD a Buy, Sell or Hold?
Currently, no data Available
What is Pediatrix Medical Group, Inc.’s price target?
Currently, no data Available
What do analysts say about Pediatrix Medical Group, Inc.?
Not enough analysts have published a price target to provide an average price target.
How can I buy shares of MD?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.